Compile Data Set for Download or QSAR
Found 496 of ic50 data for polymerid = 50001330
TargetLeucyl-cystinyl aminopeptidase(Homo sapiens (Human))
Astellas Pharma Inc.; KOTOBUKI PHARMACEUTICALS CO., LTD.

US Patent
LigandPNGBDBM271230(US10059720, Example 45 | US10975091, Example 45)copy SMILEScopy InChI
Affinity DataIC50: 0.890nMAssay Description:HEK293 cells forced to transiently express hP-LAP (J Biol Chem 1996; 271: 56-61) were prepared by lipofection, homogenized, and then subjected to ult...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2XD13Q5US Patent
TargetLeucyl-cystinyl aminopeptidase(Homo sapiens (Human))
Astellas Pharma Inc.; KOTOBUKI PHARMACEUTICALS CO., LTD.

US Patent
LigandPNGBDBM271230(US10059720, Example 45 | US10975091, Example 45)copy SMILEScopy InChI
Affinity DataIC50: 0.890nMAssay Description:hP-LAP: HEK293 cells forced to transiently express hP-LAP were prepared by lipofection, homogenized, and then subjected to ultracentrifugation at 100...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2FF3WHRUS Patent
TargetLeucyl-cystinyl aminopeptidase(Homo sapiens (Human))
Astellas Pharma Inc.; KOTOBUKI PHARMACEUTICALS CO., LTD.

US Patent
LigandPNGBDBM271257(US10059720, Example 72 | US10975091, Example 72)copy SMILEScopy InChI
Affinity DataIC50: 0.940nMAssay Description:hP-LAP: HEK293 cells forced to transiently express hP-LAP were prepared by lipofection, homogenized, and then subjected to ultracentrifugation at 100...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2FF3WHRUS Patent
TargetLeucyl-cystinyl aminopeptidase(Homo sapiens (Human))
Astellas Pharma Inc.; KOTOBUKI PHARMACEUTICALS CO., LTD.

US Patent
LigandPNGBDBM271257(US10059720, Example 72 | US10975091, Example 72)copy SMILEScopy InChI
Affinity DataIC50: 0.940nMAssay Description:HEK293 cells forced to transiently express hP-LAP (J Biol Chem 1996; 271: 56-61) were prepared by lipofection, homogenized, and then subjected to ult...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2XD13Q5US Patent
TargetLeucyl-cystinyl aminopeptidase(Homo sapiens (Human))
Astellas Pharma Inc.; KOTOBUKI PHARMACEUTICALS CO., LTD.

US Patent
LigandPNGBDBM271275(US10059720, Example 90 | US10975091, Example 90)copy SMILEScopy InChI
Affinity DataIC50: 0.950nMAssay Description:hP-LAP: HEK293 cells forced to transiently express hP-LAP were prepared by lipofection, homogenized, and then subjected to ultracentrifugation at 100...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2FF3WHRUS Patent
TargetLeucyl-cystinyl aminopeptidase(Homo sapiens (Human))
Astellas Pharma Inc.; KOTOBUKI PHARMACEUTICALS CO., LTD.

US Patent
LigandPNGBDBM271275(US10059720, Example 90 | US10975091, Example 90)copy SMILEScopy InChI
Affinity DataIC50: 0.950nMAssay Description:HEK293 cells forced to transiently express hP-LAP (J Biol Chem 1996; 271: 56-61) were prepared by lipofection, homogenized, and then subjected to ult...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2XD13Q5US Patent
TargetLeucyl-cystinyl aminopeptidase(Homo sapiens (Human))
Astellas Pharma Inc.; KOTOBUKI PHARMACEUTICALS CO., LTD.

US Patent
LigandPNGBDBM271198(US10059720, Example 13 | US10975091, Example 13)copy SMILEScopy InChI
Affinity DataIC50: 1nMAssay Description:HEK293 cells forced to transiently express hP-LAP (J Biol Chem 1996; 271: 56-61) were prepared by lipofection, homogenized, and then subjected to ult...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2XD13Q5US Patent
TargetLeucyl-cystinyl aminopeptidase(Homo sapiens (Human))
Astellas Pharma Inc.; KOTOBUKI PHARMACEUTICALS CO., LTD.

US Patent
LigandPNGBDBM271198(US10059720, Example 13 | US10975091, Example 13)copy SMILEScopy InChI
Affinity DataIC50: 1nMAssay Description:hP-LAP: HEK293 cells forced to transiently express hP-LAP were prepared by lipofection, homogenized, and then subjected to ultracentrifugation at 100...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2FF3WHRUS Patent
TargetLeucyl-cystinyl aminopeptidase(Homo sapiens (Human))
Astellas Pharma Inc.; KOTOBUKI PHARMACEUTICALS CO., LTD.

US Patent
LigandPNGBDBM271277(US10059720, Example 92 | US10975091, Example 92)copy SMILEScopy InChI
Affinity DataIC50: 1.20nMAssay Description:hP-LAP: HEK293 cells forced to transiently express hP-LAP were prepared by lipofection, homogenized, and then subjected to ultracentrifugation at 100...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2FF3WHRUS Patent
TargetLeucyl-cystinyl aminopeptidase(Homo sapiens (Human))
Astellas Pharma Inc.; KOTOBUKI PHARMACEUTICALS CO., LTD.

US Patent
LigandPNGBDBM271277(US10059720, Example 92 | US10975091, Example 92)copy SMILEScopy InChI
Affinity DataIC50: 1.20nMAssay Description:HEK293 cells forced to transiently express hP-LAP (J Biol Chem 1996; 271: 56-61) were prepared by lipofection, homogenized, and then subjected to ult...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2XD13Q5US Patent
TargetLeucyl-cystinyl aminopeptidase(Homo sapiens (Human))
Astellas Pharma Inc.; KOTOBUKI PHARMACEUTICALS CO., LTD.

US Patent
LigandPNGBDBM271190(US10059720, Example 6 | US10975091, Example 6)copy SMILEScopy InChI
Affinity DataIC50: 1.30nMAssay Description:hP-LAP: HEK293 cells forced to transiently express hP-LAP were prepared by lipofection, homogenized, and then subjected to ultracentrifugation at 100...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2FF3WHRUS Patent
TargetLeucyl-cystinyl aminopeptidase(Homo sapiens (Human))
Astellas Pharma Inc.; KOTOBUKI PHARMACEUTICALS CO., LTD.

US Patent
LigandPNGBDBM271330(US10059720, Example 145 | US10975091, Example 145)copy SMILEScopy InChI
Affinity DataIC50: 1.30nMAssay Description:hP-LAP: HEK293 cells forced to transiently express hP-LAP were prepared by lipofection, homogenized, and then subjected to ultracentrifugation at 100...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2FF3WHRUS Patent
TargetLeucyl-cystinyl aminopeptidase(Homo sapiens (Human))
Astellas Pharma Inc.; KOTOBUKI PHARMACEUTICALS CO., LTD.

US Patent
LigandPNGBDBM271272(US10059720, Example 87 | US10975091, Example 87)copy SMILEScopy InChI
Affinity DataIC50: 1.30nMAssay Description:hP-LAP: HEK293 cells forced to transiently express hP-LAP were prepared by lipofection, homogenized, and then subjected to ultracentrifugation at 100...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2FF3WHRUS Patent
TargetLeucyl-cystinyl aminopeptidase(Homo sapiens (Human))
Astellas Pharma Inc.; KOTOBUKI PHARMACEUTICALS CO., LTD.

US Patent
LigandPNGBDBM271330(US10059720, Example 145 | US10975091, Example 145)copy SMILEScopy InChI
Affinity DataIC50: 1.30nMAssay Description:HEK293 cells forced to transiently express hP-LAP (J Biol Chem 1996; 271: 56-61) were prepared by lipofection, homogenized, and then subjected to ult...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2XD13Q5US Patent
TargetLeucyl-cystinyl aminopeptidase(Homo sapiens (Human))
Astellas Pharma Inc.; KOTOBUKI PHARMACEUTICALS CO., LTD.

US Patent
LigandPNGBDBM271190(US10059720, Example 6 | US10975091, Example 6)copy SMILEScopy InChI
Affinity DataIC50: 1.30nMAssay Description:HEK293 cells forced to transiently express hP-LAP (J Biol Chem 1996; 271: 56-61) were prepared by lipofection, homogenized, and then subjected to ult...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2XD13Q5US Patent
TargetLeucyl-cystinyl aminopeptidase(Homo sapiens (Human))
Astellas Pharma Inc.; KOTOBUKI PHARMACEUTICALS CO., LTD.

US Patent
LigandPNGBDBM271272(US10059720, Example 87 | US10975091, Example 87)copy SMILEScopy InChI
Affinity DataIC50: 1.30nMAssay Description:HEK293 cells forced to transiently express hP-LAP (J Biol Chem 1996; 271: 56-61) were prepared by lipofection, homogenized, and then subjected to ult...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2XD13Q5US Patent
TargetLeucyl-cystinyl aminopeptidase(Homo sapiens (Human))
Astellas Pharma Inc.; KOTOBUKI PHARMACEUTICALS CO., LTD.

US Patent
LigandPNGBDBM271288(US10059720, Example 103 | US10975091, Example 103)copy SMILEScopy InChI
Affinity DataIC50: 1.40nMAssay Description:hP-LAP: HEK293 cells forced to transiently express hP-LAP were prepared by lipofection, homogenized, and then subjected to ultracentrifugation at 100...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2FF3WHRUS Patent
TargetLeucyl-cystinyl aminopeptidase(Homo sapiens (Human))
Astellas Pharma Inc.; KOTOBUKI PHARMACEUTICALS CO., LTD.

US Patent
LigandPNGBDBM271288(US10059720, Example 103 | US10975091, Example 103)copy SMILEScopy InChI
Affinity DataIC50: 1.40nMAssay Description:HEK293 cells forced to transiently express hP-LAP (J Biol Chem 1996; 271: 56-61) were prepared by lipofection, homogenized, and then subjected to ult...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2XD13Q5US Patent
TargetLeucyl-cystinyl aminopeptidase(Homo sapiens (Human))
Astellas Pharma Inc.; KOTOBUKI PHARMACEUTICALS CO., LTD.

US Patent
LigandPNGBDBM271218(US10059720, Example 33 | US10975091, Example 33)copy SMILEScopy InChI
Affinity DataIC50: 1.5nMAssay Description:hP-LAP: HEK293 cells forced to transiently express hP-LAP were prepared by lipofection, homogenized, and then subjected to ultracentrifugation at 100...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2FF3WHRUS Patent
TargetLeucyl-cystinyl aminopeptidase(Homo sapiens (Human))
Astellas Pharma Inc.; KOTOBUKI PHARMACEUTICALS CO., LTD.

US Patent
LigandPNGBDBM271280(US10059720, Example 95 | US10975091, Example 95)copy SMILEScopy InChI
Affinity DataIC50: 1.5nMAssay Description:HEK293 cells forced to transiently express hP-LAP (J Biol Chem 1996; 271: 56-61) were prepared by lipofection, homogenized, and then subjected to ult...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2XD13Q5US Patent
TargetLeucyl-cystinyl aminopeptidase(Homo sapiens (Human))
Astellas Pharma Inc.; KOTOBUKI PHARMACEUTICALS CO., LTD.

US Patent
LigandPNGBDBM271232(US10059720, Example 47 | US10975091, Example 47)copy SMILEScopy InChI
Affinity DataIC50: 1.5nMAssay Description:hP-LAP: HEK293 cells forced to transiently express hP-LAP were prepared by lipofection, homogenized, and then subjected to ultracentrifugation at 100...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2FF3WHRUS Patent
TargetLeucyl-cystinyl aminopeptidase(Homo sapiens (Human))
Astellas Pharma Inc.; KOTOBUKI PHARMACEUTICALS CO., LTD.

US Patent
LigandPNGBDBM271280(US10059720, Example 95 | US10975091, Example 95)copy SMILEScopy InChI
Affinity DataIC50: 1.5nMAssay Description:hP-LAP: HEK293 cells forced to transiently express hP-LAP were prepared by lipofection, homogenized, and then subjected to ultracentrifugation at 100...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2FF3WHRUS Patent
TargetLeucyl-cystinyl aminopeptidase(Homo sapiens (Human))
Astellas Pharma Inc.; KOTOBUKI PHARMACEUTICALS CO., LTD.

US Patent
LigandPNGBDBM271218(US10059720, Example 33 | US10975091, Example 33)copy SMILEScopy InChI
Affinity DataIC50: 1.5nMAssay Description:HEK293 cells forced to transiently express hP-LAP (J Biol Chem 1996; 271: 56-61) were prepared by lipofection, homogenized, and then subjected to ult...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2XD13Q5US Patent
TargetLeucyl-cystinyl aminopeptidase(Homo sapiens (Human))
Astellas Pharma Inc.; KOTOBUKI PHARMACEUTICALS CO., LTD.

US Patent
LigandPNGBDBM271232(US10059720, Example 47 | US10975091, Example 47)copy SMILEScopy InChI
Affinity DataIC50: 1.5nMAssay Description:HEK293 cells forced to transiently express hP-LAP (J Biol Chem 1996; 271: 56-61) were prepared by lipofection, homogenized, and then subjected to ult...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2XD13Q5US Patent
TargetLeucyl-cystinyl aminopeptidase(Homo sapiens (Human))
Astellas Pharma Inc.; KOTOBUKI PHARMACEUTICALS CO., LTD.

US Patent
LigandPNGBDBM271245(US10059720, Example 60 | US10975091, Example 60)copy SMILEScopy InChI
Affinity DataIC50: 1.60nMAssay Description:hP-LAP: HEK293 cells forced to transiently express hP-LAP were prepared by lipofection, homogenized, and then subjected to ultracentrifugation at 100...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2FF3WHRUS Patent
TargetLeucyl-cystinyl aminopeptidase(Homo sapiens (Human))
Astellas Pharma Inc.; KOTOBUKI PHARMACEUTICALS CO., LTD.

US Patent
LigandPNGBDBM271233(US10059720, Example 48 | US10975091, Example 48)copy SMILEScopy InChI
Affinity DataIC50: 1.60nMAssay Description:hP-LAP: HEK293 cells forced to transiently express hP-LAP were prepared by lipofection, homogenized, and then subjected to ultracentrifugation at 100...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2FF3WHRUS Patent
TargetLeucyl-cystinyl aminopeptidase(Homo sapiens (Human))
Astellas Pharma Inc.; KOTOBUKI PHARMACEUTICALS CO., LTD.

US Patent
LigandPNGBDBM271245(US10059720, Example 60 | US10975091, Example 60)copy SMILEScopy InChI
Affinity DataIC50: 1.60nMAssay Description:HEK293 cells forced to transiently express hP-LAP (J Biol Chem 1996; 271: 56-61) were prepared by lipofection, homogenized, and then subjected to ult...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2XD13Q5US Patent
TargetLeucyl-cystinyl aminopeptidase(Homo sapiens (Human))
Astellas Pharma Inc.; KOTOBUKI PHARMACEUTICALS CO., LTD.

US Patent
LigandPNGBDBM401355(US10005762, Example 35)copy SMILEScopy InChI
Affinity DataIC50: 1.60nMAssay Description:The inventors have assumed that inhibition of nocturnal activity of placental leucine aminopeptidase (P-LAP), i.e. aminopeptidase that cleaves AVP, w...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2PG1V3QUS Patent
TargetLeucyl-cystinyl aminopeptidase(Homo sapiens (Human))
Astellas Pharma Inc.; KOTOBUKI PHARMACEUTICALS CO., LTD.

US Patent
LigandPNGBDBM271233(US10059720, Example 48 | US10975091, Example 48)copy SMILEScopy InChI
Affinity DataIC50: 1.60nMAssay Description:HEK293 cells forced to transiently express hP-LAP (J Biol Chem 1996; 271: 56-61) were prepared by lipofection, homogenized, and then subjected to ult...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2XD13Q5US Patent
TargetLeucyl-cystinyl aminopeptidase(Homo sapiens (Human))
Astellas Pharma Inc.; KOTOBUKI PHARMACEUTICALS CO., LTD.

US Patent
LigandPNGBDBM271258(US10059720, Example 73 | US10975091, Example 73)copy SMILEScopy InChI
Affinity DataIC50: 1.60nMAssay Description:HEK293 cells forced to transiently express hP-LAP (J Biol Chem 1996; 271: 56-61) were prepared by lipofection, homogenized, and then subjected to ult...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2XD13Q5US Patent
TargetLeucyl-cystinyl aminopeptidase(Homo sapiens (Human))
Astellas Pharma Inc.; KOTOBUKI PHARMACEUTICALS CO., LTD.

US Patent
LigandPNGBDBM271258(US10059720, Example 73 | US10975091, Example 73)copy SMILEScopy InChI
Affinity DataIC50: 1.60nMAssay Description:hP-LAP: HEK293 cells forced to transiently express hP-LAP were prepared by lipofection, homogenized, and then subjected to ultracentrifugation at 100...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2FF3WHRUS Patent
TargetLeucyl-cystinyl aminopeptidase(Homo sapiens (Human))
Astellas Pharma Inc.; KOTOBUKI PHARMACEUTICALS CO., LTD.

US Patent
LigandPNGBDBM271229(US10059720, Example 44 | US10975091, Example 44)copy SMILEScopy InChI
Affinity DataIC50: 1.80nMAssay Description:HEK293 cells forced to transiently express hP-LAP (J Biol Chem 1996; 271: 56-61) were prepared by lipofection, homogenized, and then subjected to ult...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2XD13Q5US Patent
TargetLeucyl-cystinyl aminopeptidase(Homo sapiens (Human))
Astellas Pharma Inc.; KOTOBUKI PHARMACEUTICALS CO., LTD.

US Patent
LigandPNGBDBM271252(US10059720, Example 67 | US10975091, Example 67)copy SMILEScopy InChI
Affinity DataIC50: 1.80nMAssay Description:HEK293 cells forced to transiently express hP-LAP (J Biol Chem 1996; 271: 56-61) were prepared by lipofection, homogenized, and then subjected to ult...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2XD13Q5US Patent
TargetLeucyl-cystinyl aminopeptidase(Homo sapiens (Human))
Astellas Pharma Inc.; KOTOBUKI PHARMACEUTICALS CO., LTD.

US Patent
LigandPNGBDBM271246(US10059720, Example 61 | US10975091, Example 61)copy SMILEScopy InChI
Affinity DataIC50: 1.80nMAssay Description:HEK293 cells forced to transiently express hP-LAP (J Biol Chem 1996; 271: 56-61) were prepared by lipofection, homogenized, and then subjected to ult...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2XD13Q5US Patent
TargetLeucyl-cystinyl aminopeptidase(Homo sapiens (Human))
Astellas Pharma Inc.; KOTOBUKI PHARMACEUTICALS CO., LTD.

US Patent
LigandPNGBDBM401368(US10005762, Example 48)copy SMILEScopy InChI
Affinity DataIC50: 1.80nMAssay Description:The inventors have assumed that inhibition of nocturnal activity of placental leucine aminopeptidase (P-LAP), i.e. aminopeptidase that cleaves AVP, w...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2PG1V3QUS Patent
TargetLeucyl-cystinyl aminopeptidase(Homo sapiens (Human))
Astellas Pharma Inc.; KOTOBUKI PHARMACEUTICALS CO., LTD.

US Patent
LigandPNGBDBM271252(US10059720, Example 67 | US10975091, Example 67)copy SMILEScopy InChI
Affinity DataIC50: 1.80nMAssay Description:hP-LAP: HEK293 cells forced to transiently express hP-LAP were prepared by lipofection, homogenized, and then subjected to ultracentrifugation at 100...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2FF3WHRUS Patent
TargetLeucyl-cystinyl aminopeptidase(Homo sapiens (Human))
Astellas Pharma Inc.; KOTOBUKI PHARMACEUTICALS CO., LTD.

US Patent
LigandPNGBDBM271246(US10059720, Example 61 | US10975091, Example 61)copy SMILEScopy InChI
Affinity DataIC50: 1.80nMAssay Description:hP-LAP: HEK293 cells forced to transiently express hP-LAP were prepared by lipofection, homogenized, and then subjected to ultracentrifugation at 100...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2FF3WHRUS Patent
TargetLeucyl-cystinyl aminopeptidase(Homo sapiens (Human))
Astellas Pharma Inc.; KOTOBUKI PHARMACEUTICALS CO., LTD.

US Patent
LigandPNGBDBM271229(US10059720, Example 44 | US10975091, Example 44)copy SMILEScopy InChI
Affinity DataIC50: 1.80nMAssay Description:hP-LAP: HEK293 cells forced to transiently express hP-LAP were prepared by lipofection, homogenized, and then subjected to ultracentrifugation at 100...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2FF3WHRUS Patent
TargetLeucyl-cystinyl aminopeptidase(Homo sapiens (Human))
Astellas Pharma Inc.; KOTOBUKI PHARMACEUTICALS CO., LTD.

US Patent
LigandPNGBDBM271210(US10059720, Example 25 | US10975091, Example 25)copy SMILEScopy InChI
Affinity DataIC50: 1.80nMAssay Description:hP-LAP: HEK293 cells forced to transiently express hP-LAP were prepared by lipofection, homogenized, and then subjected to ultracentrifugation at 100...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2FF3WHRUS Patent
TargetLeucyl-cystinyl aminopeptidase(Homo sapiens (Human))
Astellas Pharma Inc.; KOTOBUKI PHARMACEUTICALS CO., LTD.

US Patent
LigandPNGBDBM271210(US10059720, Example 25 | US10975091, Example 25)copy SMILEScopy InChI
Affinity DataIC50: 1.80nMAssay Description:HEK293 cells forced to transiently express hP-LAP (J Biol Chem 1996; 271: 56-61) were prepared by lipofection, homogenized, and then subjected to ult...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2XD13Q5US Patent
TargetLeucyl-cystinyl aminopeptidase(Homo sapiens (Human))
Astellas Pharma Inc.; KOTOBUKI PHARMACEUTICALS CO., LTD.

US Patent
LigandPNGBDBM271290(US10059720, Example 105 | US10975091, Example 105)copy SMILEScopy InChI
Affinity DataIC50: 1.90nMAssay Description:hP-LAP: HEK293 cells forced to transiently express hP-LAP were prepared by lipofection, homogenized, and then subjected to ultracentrifugation at 100...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2FF3WHRUS Patent
TargetLeucyl-cystinyl aminopeptidase(Homo sapiens (Human))
Astellas Pharma Inc.; KOTOBUKI PHARMACEUTICALS CO., LTD.

US Patent
LigandPNGBDBM271211(US10059720, Example 26 | US10975091, Example 26)copy SMILEScopy InChI
Affinity DataIC50: 1.90nMAssay Description:HEK293 cells forced to transiently express hP-LAP (J Biol Chem 1996; 271: 56-61) were prepared by lipofection, homogenized, and then subjected to ult...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2XD13Q5US Patent
TargetLeucyl-cystinyl aminopeptidase(Homo sapiens (Human))
Astellas Pharma Inc.; KOTOBUKI PHARMACEUTICALS CO., LTD.

US Patent
LigandPNGBDBM271211(US10059720, Example 26 | US10975091, Example 26)copy SMILEScopy InChI
Affinity DataIC50: 1.90nMAssay Description:hP-LAP: HEK293 cells forced to transiently express hP-LAP were prepared by lipofection, homogenized, and then subjected to ultracentrifugation at 100...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2FF3WHRUS Patent
TargetLeucyl-cystinyl aminopeptidase(Homo sapiens (Human))
Astellas Pharma Inc.; KOTOBUKI PHARMACEUTICALS CO., LTD.

US Patent
LigandPNGBDBM271290(US10059720, Example 105 | US10975091, Example 105)copy SMILEScopy InChI
Affinity DataIC50: 1.90nMAssay Description:HEK293 cells forced to transiently express hP-LAP (J Biol Chem 1996; 271: 56-61) were prepared by lipofection, homogenized, and then subjected to ult...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2XD13Q5US Patent
TargetLeucyl-cystinyl aminopeptidase(Homo sapiens (Human))
Astellas Pharma Inc.; KOTOBUKI PHARMACEUTICALS CO., LTD.

US Patent
LigandPNGBDBM271241(US10059720, Example 56 | US10975091, Example 56)copy SMILEScopy InChI
Affinity DataIC50: 2nMAssay Description:HEK293 cells forced to transiently express hP-LAP (J Biol Chem 1996; 271: 56-61) were prepared by lipofection, homogenized, and then subjected to ult...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2XD13Q5US Patent
TargetLeucyl-cystinyl aminopeptidase(Homo sapiens (Human))
Astellas Pharma Inc.; KOTOBUKI PHARMACEUTICALS CO., LTD.

US Patent
LigandPNGBDBM50245396(CHEMBL4101200)copy SMILEScopy InChI
Affinity DataIC50: 2nMAssay Description:Inhibition of IRAP (unknown origin) expressed in HEK 293S GnTI(-) cells by in vitro fluorimetric assayMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2PK0JJGPubMed
TargetLeucyl-cystinyl aminopeptidase(Homo sapiens (Human))
Astellas Pharma Inc.; KOTOBUKI PHARMACEUTICALS CO., LTD.

US Patent
LigandPNGBDBM271241(US10059720, Example 56 | US10975091, Example 56)copy SMILEScopy InChI
Affinity DataIC50: 2nMAssay Description:hP-LAP: HEK293 cells forced to transiently express hP-LAP were prepared by lipofection, homogenized, and then subjected to ultracentrifugation at 100...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2FF3WHRUS Patent
TargetLeucyl-cystinyl aminopeptidase(Homo sapiens (Human))
Astellas Pharma Inc.; KOTOBUKI PHARMACEUTICALS CO., LTD.

US Patent
LigandPNGBDBM401389(US10005762, Example 69)copy SMILEScopy InChI
Affinity DataIC50: 2.10nMAssay Description:The inventors have assumed that inhibition of nocturnal activity of placental leucine aminopeptidase (P-LAP), i.e. aminopeptidase that cleaves AVP, w...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2PG1V3QUS Patent
TargetLeucyl-cystinyl aminopeptidase(Homo sapiens (Human))
Astellas Pharma Inc.; KOTOBUKI PHARMACEUTICALS CO., LTD.

US Patent
LigandPNGBDBM271240(US10059720, Example 55 | US10975091, Example 55)copy SMILEScopy InChI
Affinity DataIC50: 2.10nMAssay Description:HEK293 cells forced to transiently express hP-LAP (J Biol Chem 1996; 271: 56-61) were prepared by lipofection, homogenized, and then subjected to ult...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2XD13Q5US Patent
TargetLeucyl-cystinyl aminopeptidase(Homo sapiens (Human))
Astellas Pharma Inc.; KOTOBUKI PHARMACEUTICALS CO., LTD.

US Patent
LigandPNGBDBM271240(US10059720, Example 55 | US10975091, Example 55)copy SMILEScopy InChI
Affinity DataIC50: 2.10nMAssay Description:hP-LAP: HEK293 cells forced to transiently express hP-LAP were prepared by lipofection, homogenized, and then subjected to ultracentrifugation at 100...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2FF3WHRUS Patent
Displayed 1 to 50 (of 496 total ) | Next | Last >>
Jump to: